is tirzepatide a glp-1 or glp 2 Understand GLP-1/GIP Dual Agonist and Its Effect on Current Weight Loss Therapy Management of type 2 diabetes

At the currently approved maximum dose of 14mg, the PIONEER clinical trials showed weight loss of approximately 4-5kg (about 4-5% of body weight) over 26 weeks in patients with type 2 diabetes

Nutrient Information: Daily Intake Amount: One capsule * NRV is the Nutrient Reference Value NRV not yet established Dietary Information: This product is suitable for the following requirements: Allergens: This product is hypoallergenic / does not contain any of the 14 major allergens listed in Annex II (1169/2011) of the EU Food Information for Consumers Regulation

Symptom Tracking: Keep track of each clients symptoms over time, allowing for easy identification of trends and correlations between GLP-1 usage and symptom presentation

Let me help you develop patient-centered nutrition services that integrate seamlessly into clinical care

Open access Macedonian journal of medical sciences , 7 (3), 495499